	Dynamic transcriptional immune landscape in response to NK-cell therapy combined with gemcitabine plus S-1 in advanced pancreatic cancer: a phase 1b/2 trial. Signal Transduct Target Ther Tan Q, Li Y, Liu C, Xu J, Tong J, Yu J, Huang Y, Hu X, Qin S, Xiao F, Zhao Y, Ma J. PMID: 41266303 [PubMed - indexed for MEDLINE]
	Reappraisal of surgical indication of mucinous cystic neoplasm of the pancreas: a systematic review and meta-analysis. Int J Surg Yun WG, Seo Y, Han Y, Lee I, Choi GW, Chae YS, Cho YJ, Jung HS, Kwon W, Park JS, Jang JY. PMID: 41263396 [PubMed - as supplied by publisher]
	Second Cancer Incidence and Cause-Specific Mortality in Primary Gastrointestinal Non-Hodgkin Lymphoma Survivors: A Population-Based Cohort Study. Cancer Med Wu J, Yang J, Ding Y, Wang J, Cheng X, You L, Zhao F. PMID: 41263308 [PubMed - indexed for MEDLINE]
	Primary pancreatic lymphoma masquerading as pancreatic carcinoma: A case report and literature review. Medicine (Baltimore) Xu X, Zhang T, Liu J, Li X, Wang G. PMID: 41261693 [PubMed - indexed for MEDLINE]
	Solid pseudopapillary neoplasm of the pancreas: A case report. Medicine (Baltimore) Bakos M, Durdik S, Dubaj M, Stulajterova I, Pobeskova M, Dobrovanov O, Vidiscak M. PMID: 41261629 [PubMed - indexed for MEDLINE]
	Adherence to the 2018 World Cancer Research Fund/American Institute for Cancer Research Cancer Prevention Recommendations and risk of lifestyle-related cancers in the prostate, lung, colorectal, and ovarian cancer screening trial. BJC Rep Malcomson FC, Shams-White MM, Reedy J, Huang WY, Moore SC, Loftfield E. PMID: 41261199 [PubMed]
	5-hydroxymethylcytosine analysis reveals stable epigenomic changes in tumor tissue that enable cancer detection in cell-free DNA. Commun Biol Xue Y, Ning Y, Friedl V, Haan D, Bergamaschi A, Guler GD, Hazen K, Scott A, Phillips T, McCarthy E, Ellison CK, Malta R, Nguyen A, Lopez V, Cavet R, Peters M, Sheard J, Gibb W, Chowdhury S, Volkmuth W, Levy S. PMID: 41261178 [PubMed - indexed for MEDLINE]
	Prognostic value of composite inflammatory prognostic model in pancreatic cancer. Mol Cell Probes Wei Q, Li Z, Feng H, Zhang J, Wei L. PMID: 41260275 [PubMed - as supplied by publisher]
	zDHHC-mediated palmitoylation modification patterns and tumor immune microenvironment infiltration characterization in pancreatic cancer. Int Immunopharmacol Lu C, He Y, Zhang LQ, Miao JY, Wang W. PMID: 41260168 [PubMed - as supplied by publisher]
	Clinical Implications of Dihydropyrimidine Dehydrogenase Deficiency in GI and Hepatopancreaticobiliary Cancers Treated With Fluoropyrimidines: A Prospective Observational Study. JCO Glob Oncol Goel V, Basu DA, Jain A, Patnaik N, Jaju A, Mehta A, Talwar V. PMID: 41259730 [PubMed - indexed for MEDLINE]
	DNA methylation-mediated ADA overexpression drives pancreatic cancer progression. Discov Oncol Zeng J, Jiao J, Lin B, Li H, Xu W. PMID: 41258527 [PubMed - as supplied by publisher]
	Risk of all-cause death and pancreatic events following GLP-1 RA initiation in people with obesity or type 2 diabetes: observations from a federated research network. Cardiovasc Diabetol Tartaglia E, Bucci T, Rossi M, Rigutini AG, Askarinejad A, Alam U, Nabrdalik K, Boriani G, Lip GYH. PMID: 41257737 [PubMed - indexed for MEDLINE]
	Global, regional, and national burden and trends of pancreatic cancer, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Front Oncol Liu C, Liu P, Liu X, Niu W, Wu P, Yu J. PMID: 41256325 [PubMed]
	Progression-free survival for unresectable non-metastatic locally advanced pancreatic cancer after surgical microwave ablation plus durvalumab and tremelimumab: phase-2 non-randomized prospective clinical trial. Commun Med (Lond) Topal H, Venken T, Bassez A, Chiritescu G, Van Cutsem E, van der Merwe S, Lambrechts D, Topal B. PMID: 41254229 [PubMed]
	Stereotactic body radiotherapy versus laparoscopic liver resection for single hepatocellular carcinoma ≤ 5 cm: a retrospective, multicenter, cohort study. Sci Rep Zhou B, Ma Z, Cheng X, Yan M, Duan Y, Ye J, Guo L, Xue J, Meng Y, Cheng S, Guo W. PMID: 41254049 [PubMed - indexed for MEDLINE]
	Migrasome-related LncRNA features predict immune microenvironment and prognosis in pancreatic cancer. Sci Rep Li W, Cao Y, Sun X, Wang T, Xu P, Li P. PMID: 41253932 [PubMed - indexed for MEDLINE]
	Endoscopic ultrasound features of pancreatic serous cystic neoplasms: a single-center experience. Med Ultrason Liu JH, Fan CX, Jiang FX, Xie XX, Guo YY, Wang R. PMID: 41252616 [PubMed - as supplied by publisher]
	A Phase I/II Study Protocol of a Novel Neoadjuvant 'PRaG' Regimen (Radiotherapy, GM-CSF, and Cadonilimab) with AG Chemotherapy to Improve Resectability in Locally Advanced Pancreatic Ductal Adenocarcinoma: The NeoPRAG Study. Technol Cancer Res Treat Xu M, Zhang J, Kong Y, Xing P, Zhao X, Chen R, Pu Y, Chen W, Zhang L. PMID: 41252443 [PubMed - indexed for MEDLINE]
	Comprehensive Evaluation of Lipids, Lipoproteins, and Metabolites Associated with Gastrointestinal Cancer Risk. Cancer Epidemiol Biomarkers Prev Sun M, Chen W, Cheng X, Cui H, Huang J, Huang R, Li Y, Ma Y, Hang D. PMID: 41252339 [PubMed - as supplied by publisher]
	The Role of PI3K Inhibition in Suppressing Pancreatic Cancer Progression: Mechanistic Insights From Copanlisib Studies. Arch Pharm (Weinheim) Yu L, Wu J, Wan S, Zhu J. PMID: 41251088 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 57916

Page 1 of 2896



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy